| |
| Issue |
Title |
| |
| Vol 5, No 3 (2025) |
Development of risk management processes for the quality of medicinal products in supply chains |
Abstract
PDF (Rus)
|
|
A. A. Taube |
| |
| Vol 5, No 3 (2025) |
Prospects for the application of individualized integrated analysis of adverse events in vaccine clinical trials |
Abstract
PDF (Rus)
|
|
A. B. Verveda, G. I. Syraeva, V. B. Vasilyuk, M. V. Faraponova |
| |
| Vol 4, No 4 (2024) |
Prerequisites and limitations of the use of oral anticoagulants in pregnant women in real-world clinical practice |
Abstract
PDF (Rus)
|
|
Kh. A. Zagorodnikova, O. A. Bettikher, I. Ye. Zazerskaya |
| |
| Vol 4, No 1 (2024) |
Current issues related to the off-label use of drugs and their potential solutions |
Abstract
PDF (Rus)
|
|
K. S. Radaeva, S. A. Mishinova |
| |
| Vol 3, No 2 (2023) |
Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review |
Abstract
PDF (Rus)
|
|
A. Sh. Motrinchuk, O. A. Loginovskaya, V. P. Kolbatov |
| |
| Vol 3, No 1 (2023) |
Assessing the risks of abuse of opioids in real-world data |
Abstract
PDF (Rus)
|
|
M. V. Pchelintsev |
| |
| Vol 2, No 1 (2022) |
Aspects of the safe use of medicinal products based on medicinal plant materials in COVID-19 |
Abstract
PDF (Rus)
|
|
A. A. Taube |
| |
| Vol 1, No 1 (2021) |
Paracetamol safety in COVID-19 |
Abstract
PDF (Rus)
PDF (0,2 Mb) (Eng)
|
|
B. K. Romanov |
| |
| 1 - 8 of 8 Items |
|
